| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
3,442 |
2,095 |
$334K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,485 |
4,413 |
$166K |
| 92134 |
|
14,523 |
8,773 |
$138K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
12,997 |
7,293 |
$105K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,265 |
2,121 |
$74K |
| 4177F |
|
3,975 |
2,806 |
$32K |
| 92250 |
|
3,098 |
1,802 |
$23K |
| 2022F |
|
2,182 |
1,617 |
$10K |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
8,991 |
6,135 |
$7K |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
3,892 |
2,606 |
$7K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
345 |
151 |
$6K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
8,044 |
5,955 |
$4K |
| J7999 |
Compounded drug, not otherwise classified |
2,172 |
1,347 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
198 |
145 |
$2K |
| J9035 |
Injection, bevacizumab, 10 mg |
363 |
317 |
$2K |
| 93886 |
|
235 |
148 |
$1K |
| J9999 |
Not otherwise classified, antineoplastic drugs |
162 |
123 |
$577.90 |
| 93892 |
|
231 |
148 |
$533.85 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
8,989 |
6,030 |
$234.55 |
| 1036F |
|
9,213 |
6,780 |
$90.76 |
| J3490 |
Unclassified drugs |
1,870 |
952 |
$41.60 |
| 93890 |
|
235 |
148 |
$23.07 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
809 |
605 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
579 |
336 |
$0.00 |
| 92226 |
|
64 |
25 |
$0.00 |
| 2024F |
|
2,089 |
1,567 |
$0.00 |
| 2026F |
|
2,050 |
1,541 |
$0.00 |
| 92225 |
|
56 |
42 |
$0.00 |
| 5010F |
|
843 |
614 |
$0.00 |
| 76512 |
|
20 |
12 |
$0.00 |
| 0517F |
|
43 |
25 |
$0.00 |